Industries > Pharma > Drug Delivery Technologies Market Forecast 2019-2029

Drug Delivery Technologies Market Forecast 2019-2029

Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular, Nasal/Buccal Drug Delivery Technologies, Biologics, Vaccines

PUBLISHED: 27 February 2019
PAGES: 180
PRODUCT CODE: PHA0356

Clear
WOOCS 2.2.1

The Drug Delivery Technologies market is estimated to grow at a CAGR of 8.3% in the first half of the forecast period. The Oral Drug Delivery Technologies submarket held 50% of this market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand-new report, you will find 180-page report and you will receive 60 tables and 68 figures – all unavailable elsewhere.

The 180-page report provides clear detailed insight into the Drug Delivery Technologies market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Drug Delivery Technologies market forecasts from 2019-2029

• Drug Delivery Technologies submarket forecasts from 2019-2029 covering:
• Oral Drug Delivery Technology
• Inhalable Drug Delivery Technology
• Injectable/Implantable Drug Delivery Technology
• Transdermal Drug Delivery Technology
• Ocular Drug Delivery Technology
• Nasal/Buccal Drug Delivery Technology

This report discusses the drivers and restraints of each submarket.

• Drug Delivery Technologies Market regional and national market forecasts from 2019-2029, covering:
• North America: US, Canada, Mexico
• Europe: Germany, France, UK, Italy, Spain, Rest of Europe
• Asia-Pacific: China, Japan, India, Australia, South Korea, Rest of Asia-Pacific
• Latin America: Brazil and Rest of Latin America
• Rest of the World: Middle East, Africa

Drug Delivery Technologies Market Forecast 2019-2029

• Assessment of the leading companies in the Drug Delivery Technologies market:
• 3M
• Alkermes PLC
• Altea Therapeutics Corporation
• Antares Pharma Inc.
• Applied Pharma Research S.A. (APR)
• Becton, Dickinson & Company
• Ethypharm SA
• Glycologic Limited
• Intercell AG
• NanoPass Technologies Ltd.
• pSivida

SWOT analysis of the drug delivery technologies market

Visiongain’s study is intended for anyone requiring commercial analyses for the Drug Delivery Technologies Market and leading companies. You find data, trends and predictions.

Buy our report today Drug Delivery Technologies Market : Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular, Nasal/Buccal Drug Delivery Technologies, Biologics, Vaccines.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Drug Delivery Technologies Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Drug Delivery Technologies Market Forecast 2019-2029


Latest Pharma news

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

READ

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

READ

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

READ

Visiongain Publishes Drug Discovery Outsourcing Market Report 2020-2030

The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.

07 September 2020

READ

Categories

Category